Caxton Associates (New York)’s C.H. Robinson CHRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-6,329
Closed -$579K – 511
2022
Q4
$579K Buy
+6,329
New +$603K 0.04% 212
2022
Q3
– Sell
-2,064
Closed -$209K – 498
2022
Q2
$209K Buy
+2,064
New +$215K 0.02% 459
2021
Q3
– Sell
-4,356
Closed -$408K – 463
2021
Q2
$408K Buy
+4,356
New +$425K 0.04% 228
2018
Q4
– Sell
-3,524
Closed -$345K – 307
2018
Q3
$345K Buy
+3,524
New +$331K 0.02% 300

Other funds holding CHRW

Caxton Associates (New York)'s CHRW Position: Q1 2023 in Review

Caxton Associates (New York) sold out of C.H. Robinson (CHRW) in Q1 2023, closing a stake of 6,329 shares — an estimated $579K sold.

Caxton Associates (New York) first reported a position in CHRW in Q3 2018 and held it in 4 quarters. The position peaked at $579K in Q4 2022. 610 funds tracked by Wall St. Rank hold CHRW as of Q1 2023.

  • Caxton Associates (New York) reported no remaining C.H. Robinson position as of Q1 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 6,329 C.H. Robinson shares in Q1 2023, an estimated $579K.
  • Caxton Associates (New York) first reported a position in C.H. Robinson in Q3 2018 and held it in 4 quarters.
  • Caxton Associates (New York)'s C.H. Robinson position peaked at $579K in Q4 2022.
  • 610 funds tracked by Wall St. Rank held C.H. Robinson as of Q1 2023.

Based on Caxton Associates (New York)'s 13F filing for Q1 2023, filed 15 May 2023.